Condition: Human Papillomavirus Viruses · Mesenchymal Stem Cells · Sponsor: Shanghai East Hospital
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
This description comes directly from the study's public registry record.
Jingjing Liu, M.D,.PH.D. · 13795350828 · liu.doctor@hotmail.com
Always discuss trial participation with your own doctor first.
| Shanghai Shanghai East Hospital, Tongji University School of Medicine | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06610773